Galderma starts 2024 with impressive growth, reporting over $1 billion in sales and confirming its financial outlook for the year.

Swiss lawmakers seek to fortify national security and economic stability through a proposed Investment Review Act aimed at scrutinising foreign takeovers.

Chairman Colm Kelleher voices strong concerns over proposed additional capital requirements for big banks, emphasising the strength of UBS's business model and capitalisation.

Early polling indicates Swiss voters are likely to approve initiatives on healthcare cost control and energy tax waivers, with significant support varying across demographic lines.

Switzerland's shipping industry faces continued taxation on profit rather than tonnage, the National Council's committee opposes the changes.

As Roche navigates the final impacts of reduced coronavirus sales and a strong Swiss franc, the company maintains its outlook for 2024.

Decline in Swiss banks job market deepens post-UBS and Credit Suisse merger, with significant cuts projected by 2026.

Shareholder discontent looms over UBS's upcoming AGM, with criticism focused on CEO Sergio Ermotti's CHF 14 million salary and the bank's sustainability policies.

Recent statistics reveal significant demographic and social shifts in Swiss urban centres, including population growth, religious affiliations, and political dynamics.

Switzerland reports a significant decrease in the value of Russian assets frozen under sanctions, as valuations drop.

The Swiss biotech sector saw record-breaking growth last year. KEYSTONE/Laurent Gillieron The Swiss biotech sector with further records last year.

Novartis kicks off 2024 with robust financial growth, spurred by strategic focus on pharmaceuticals, leading to an upward revision of annual forecasts.

Amid fluctuating market dynamics, Kuehne+Nagel reports a dip in first-quarter financial performance, though signs of recovery appear with increased demand in sea and air freight services.

The MSC Foundation supports Mercy Ships with a new hospital ship set to enhance medical care across Africa.

Justice Minister Beat Jans spearheads collaborative efforts among German-speaking nations to address immigration challenges and combat organized crime.

Analysts predict a historic profit for the Swiss National Bank in the first quarter of 2024, surpassing past records due to favourable exchange rates and asset valuations.

Starting July 1, 2024, the Swiss National Bank will enforce stricter minimum reserve requirements, aiming to bolster monetary policy effectiveness.

With no investors in sight, Hochdorf directs efforts towards selling its Swiss Nutrition subsidiary amid uncertainties about its holding company's future.